- Home
- PCRX vs PHR Comparison
PCRX vs PHR Comparison
Compare PCRX & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- PHR
- Stock Information
- Founded
- PCRX 2006
- PHR 2005
- Country
- PCRX United States
- PHR United States
- Employees
- PCRX N/A
- PHR N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- PHR Business Services
- Sector
- PCRX Health Care
- PHR Consumer Discretionary
- Exchange
- PCRX Nasdaq
- PHR Nasdaq
- Market Cap
- PCRX 604.7M
- PHR N/A
- IPO Year
- PCRX 2011
- PHR 2019
- Fundamental
- Price
- PCRX $16.95
- PHR $20.43
- Analyst Decision
- PCRX Buy
- PHR Strong Buy
- Analyst Count
- PCRX 10
- PHR 12
- Target Price
- PCRX $27.30
- PHR $29.42
- AVG Volume (30 Days)
- PCRX 940.9K
- PHR 323.4K
- Earning Date
- PCRX 10-31-2024
- PHR 12-03-2024
- Dividend Yield
- PCRX N/A
- PHR N/A
- EPS Growth
- PCRX N/A
- PHR N/A
- EPS
- PCRX 1.28
- PHR N/A
- Revenue
- PCRX $690,310,000.00
- PHR $389,956,000.00
- Revenue This Year
- PCRX $4.77
- PHR $18.80
- Revenue Next Year
- PCRX N/A
- PHR $14.98
- P/E Ratio
- PCRX $13.01
- PHR N/A
- Revenue Growth
- PCRX 3.15
- PHR 22.10
- 52 Week Low
- PCRX $11.16
- PHR $12.05
- 52 Week High
- PCRX $35.95
- PHR $29.16
- Technical
- Relative Strength Index (RSI)
- PCRX 65.22
- PHR 31.92
- Support Level
- PCRX $15.16
- PHR $20.71
- Resistance Level
- PCRX $16.17
- PHR $21.36
- Average True Range (ATR)
- PCRX 0.67
- PHR 0.71
- MACD
- PCRX 0.20
- PHR -0.09
- Stochastic Oscillator
- PCRX 90.59
- PHR 14.67
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.